Tower Research Capital (TRC)’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $115K | Sell |
|
|||||
|
2025
Q2 | $147K | Buy |
|
|||||
|
2025
Q1 | $33.8K | Sell |
|
|||||
|
2024
Q4 | $528K | Buy |
|
|||||
|
2024
Q3 | $364K | Sell |
|
|||||
|
2024
Q2 | $485K | Buy |
|
|||||
|
2024
Q1 | $30.8K | Sell |
|
|||||
|
2023
Q4 | $124K | Buy |
|
|||||
|
2023
Q3 | $51.5K | Sell |
|
|||||
|
2023
Q2 | $148K | Buy |
|
|||||
|
2023
Q1 | $78K | Buy |
|
|||||
|
2022
Q4 | $13K | Sell |
|
|||||
|
2022
Q3 | $192K | Sell |
|
|||||
|
2022
Q2 | $307K | Buy |
|
|||||
|
2022
Q1 | $111K | Sell |
|
|||||
|
2021
Q4 | $138K | Sell |
|
|||||
|
2021
Q3 | $654K | Buy |
|
|||||
|
2021
Q2 | $45K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $124K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $8K | Buy |
|
|||||
|
2019
Q4 | $11K | Buy |
|
|||||
|
2019
Q3 | $5K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $9K | Sell |
|
|||||
|
2018
Q4 | $9K | Buy |
|
|||||
|
2018
Q3 | $8K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $1K | Sell |
|
|||||
|
2017
Q3 | $52K | Buy |
|
|||||
|
2017
Q2 | $1K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $44K | Buy |
|
|||||
|
2016
Q3 | $5K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $0 | Sell |
|
|||||
|
2015
Q4 | $10K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $70K | Buy |
|
|||||
|
2015
Q1 | $37K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $55K | Buy |
|
|||||
|
2013
Q4 | $53K | Sell |
|
|||||
|
2013
Q3 | $254K | Buy |
|